Chest Medicine (all articles) | Page 21 of 169 | Links Medicus Content Curation & Alerts in Medicine

New research found that for individuals in general (medical and surgical) care in hospital, occult hypoxemia was more common for black patients than for white patients https://t.co/DrNlaIE7ho

— The BMJ (@bmj_latest) July 6, 2022

Effect of comprehensive smoke-free legislation on neonatal and infant mortality across 106 middle-income countries.

7 Jul, 2022 | 12:26h | UTC

Effect of comprehensive smoke-free legislation on neonatal mortality and infant mortality across 106 middle-income countries: a synthetic control study – The Lancet Public Health

RCT | High-dose dexamethasone and oxygen support strategies in intensive care unit patients with severe COVID-19 acute hypoxemic respiratory failure.

6 Jul, 2022 | 11:51h | UTC

High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure: The COVIDICUS Randomized Clinical Trial – JAMA Internal Medicine

Commentary on Twitter

In this RCT, high-dose dexamethasone did not significantly improve the 60-day survival. The oxygenation strategy in initially non-intubated patients did not significantly modify the 28-day risk of invasive mechanical ventilation requirement. https://t.co/ZNajW2KBKR

— JAMA Internal Medicine (@JAMAInternalMed) July 5, 2022

FDA orders Juul to remove all its e-cigarettes from US market.

6 Jul, 2022 | 11:46h | UTC

FDA orders Juul to remove all its e-cigarettes from US market – The BMJ

RCT | Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis.

6 Jul, 2022 | 11:31h | UTC

Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial – Thorax

Commentary: Does Azithromycin antagonize the effect of inhaled tobramycin in cystic fibrosis? – Medical Dialogues

Commentary on Twitter

Original research: Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trialhttps://t.co/z9dGX52dAe pic.twitter.com/tpiOqIIQjb

— ThoraxBMJ (@ThoraxBMJ) May 23, 2022

Exercise-induced laryngeal obstruction (EILO) in athletes: a narrative review by a subgroup of the IOC Consensus on acute respiratory illness in the athlete.

5 Jul, 2022 | 11:59h | UTC

Exercise-induced laryngeal obstruction (EILO) in athletes: a narrative review by a subgroup of the IOC Consensus on ‘acute respiratory illness in the athlete’ – British Journal of Sports Medicine

M-A | Predictors of sleep disordered breathing in children with Down syndrome.

5 Jul, 2022 | 11:33h | UTC

Predictors of sleep disordered breathing in children with Down syndrome: a systematic review and meta-analysis – European Respiratory Review

Review | Cough hypersensitivity and chronic cough.

4 Jul, 2022 | 12:59h | UTC

Cough hypersensitivity and chronic cough – Nature Reviews Disease Primers (if the link is paywalled, try this one)

See also: Infographic (if the link is paywalled, try this one)

Commentary on Twitter

#Cough is mediated by a complex set of neurobiological processes involving the peripheral nervous system, brainstem and higher brain. #ChronicCough https://t.co/DGgjk2Iyji pic.twitter.com/nrmJne7Ir8

— Nature Reviews Disease Primers (@DiseasePrimers) July 2, 2022

Bad news for Paxlovid? Coronavirus can find multiple ways to evade COVID-19 drug.

4 Jul, 2022 | 12:57h | UTC

Bad news for Paxlovid? Coronavirus can find multiple ways to evade COVID-19 drug – Science

Opinion | FDA: Don’t rush a move to change the Covid-19 vaccine composition.

4 Jul, 2022 | 12:53h | UTC

FDA: Don’t rush a move to change the Covid-19 vaccine composition – STAT

Guideline | Malignancy risk stratification for solitary pulmonary nodule.

4 Jul, 2022 | 12:33h | UTC

Malignancy risk stratification for solitary pulmonary nodule: A clinical practice guideline – Journal of Evidence-Based Medicine

Brief Review | Ventilator-associated pneumonia.

4 Jul, 2022 | 12:15h | UTC

Ventilator-associated pneumonia – Intensive Care Medicine (if the link is paywalled, try this one in PMC)

Commentary on Twitter

VAP, main challenges & lessons learned
➡️ epidemiology: surveillance & data from LMICs
➡️ pathophysiology
➡️ prevention bundle
➡️ gold standard for diagnosis & microbiology
➡️ treatment: appropriate/timely ABTs
➡️ MDR pathogens
➡️ #COVID19: VAP's back
? https://t.co/oYblI6OGLK pic.twitter.com/qXWcABsU0H

— Intensive Care Medicine (@yourICM) July 1, 2022

2022 Guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.

1 Jul, 2022 | 11:50h | UTC

2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 – The Lancet Oncology

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy – Cochrane Library

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer – Blood Advances

Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review

Two new studies show no benefit of Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19.

1 Jul, 2022 | 11:49h | UTC

Study 1: Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial – The Lancet Haematology

Study 2: Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial – The Lancet Haematology

Commentaries:

Antithrombotic prophylaxis for symptomatic outpatients with COVID-19: less is consistently more – The Lancet Haematology

Antithrombotic Prophylaxis No Help in Outpatients With COVID — Two trials show no differences between patients who received enoxaparin vs standard of care – MedPage Today (free registration required)

Commentary on Twitter (thread – click for more)

Early in the pandemic we wondered whether antithrombotic therapy in outpatients with #COVID19 would prevent #thrombosis ❓

Several trials were started globally and the ACTIV-4B trial was previously reported⬇️ https://t.co/Q15WcZwDIA

Now, we publish the OVID and ETHIC trials?

— The Lancet Haematology (@TheLancetHaem) June 30, 2022

Accuracy of rapid antigen vs. RT-PCR testing for SARS-CoV-2 infection in college athletes during prevalence of the Omicron variant.

1 Jul, 2022 | 11:39h | UTC

Accuracy of Rapid Antigen vs Reverse Transcriptase–Polymerase Chain Reaction Testing for SARS-CoV-2 Infection in College Athletes During Prevalence of the Omicron Variant – JAMA Network Open

Commentary on Twitter

In this case series of college athletes returning to campus during Omicron, rapid antigen tests were 63% sensitive, >99% specific for #COVID19, similar to previous strains and less well in detecting asymptomatic #SARSCoV2. @helixcardinal @stanford_ortho https://t.co/SBPr6NQ9Na

— JAMA Network Open (@JAMANetworkOpen) June 15, 2022